[go: up one dir, main page]

SE459847B - Osmotiskt system med omedelbar laekemedelstillgaenglighet - Google Patents

Osmotiskt system med omedelbar laekemedelstillgaenglighet

Info

Publication number
SE459847B
SE459847B SE8401185A SE8401185A SE459847B SE 459847 B SE459847 B SE 459847B SE 8401185 A SE8401185 A SE 8401185A SE 8401185 A SE8401185 A SE 8401185A SE 459847 B SE459847 B SE 459847B
Authority
SE
Sweden
Prior art keywords
laminate
drug
osmotic
wall
semipermeable
Prior art date
Application number
SE8401185A
Other languages
English (en)
Swedish (sv)
Other versions
SE8401185D0 (sv
SE8401185L (sv
Inventor
G V Guittard
J C Deters
F Theeuwes
R Cortese
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of SE8401185D0 publication Critical patent/SE8401185D0/xx
Publication of SE8401185L publication Critical patent/SE8401185L/
Publication of SE459847B publication Critical patent/SE459847B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8401185A 1983-03-04 1984-03-02 Osmotiskt system med omedelbar laekemedelstillgaenglighet SE459847B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/472,333 US4576604A (en) 1983-03-04 1983-03-04 Osmotic system with instant drug availability

Publications (3)

Publication Number Publication Date
SE8401185D0 SE8401185D0 (sv) 1984-03-02
SE8401185L SE8401185L (sv) 1984-09-05
SE459847B true SE459847B (sv) 1989-08-14

Family

ID=23875096

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8401185A SE459847B (sv) 1983-03-04 1984-03-02 Osmotiskt system med omedelbar laekemedelstillgaenglighet

Country Status (22)

Country Link
US (1) US4576604A (de)
JP (1) JPS59167513A (de)
AT (1) AT397179B (de)
AU (1) AU568621B2 (de)
BE (1) BE898820A (de)
BR (1) BR8400997A (de)
CA (1) CA1242122A (de)
CH (1) CH660124A5 (de)
DE (1) DE3407873A1 (de)
DK (1) DK162470C (de)
ES (1) ES8503499A1 (de)
FR (1) FR2541896B1 (de)
GB (1) GB2135880B (de)
IE (1) IE56606B1 (de)
IL (1) IL71112A (de)
IT (1) IT1182253B (de)
MX (1) MX165227B (de)
NL (1) NL192720C (de)
NO (1) NO170667C (de)
NZ (1) NZ206988A (de)
SE (1) SE459847B (de)
ZA (1) ZA84259B (de)

Families Citing this family (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU571922B2 (en) * 1984-01-26 1988-04-28 Schering Agrochemicals Limited Veterinary implants comprising melatonin and derivatives thereof
US4618487A (en) * 1984-07-06 1986-10-21 Alza Corporation Device for administering calcium ascorbate
US4769027A (en) * 1984-08-15 1988-09-06 Burroughs Wellcome Co. Delivery system
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
US4786501A (en) * 1985-07-15 1988-11-22 International Minerals & Chemical Corp. Cylindrical implants for the controlled release of growth hormones
US4643731A (en) * 1985-08-16 1987-02-17 Alza Corporation Means for providing instant agent from agent dispensing system
US4698062A (en) * 1985-10-30 1987-10-06 Alza Corporation Medical device for pulsatile transdermal delivery of biologically active agents
US4898733A (en) * 1985-11-04 1990-02-06 International Minerals & Chemical Corp. Layered, compression molded device for the sustained release of a beneficial agent
US4662880A (en) * 1986-03-14 1987-05-05 Alza Corporation Pseudoephedrine, brompheniramine therapy
ES2019634B3 (es) * 1986-04-17 1991-07-01 Alza Corp Terapia con clorfeniramina.
US4857330A (en) * 1986-04-17 1989-08-15 Alza Corporation Chlorpheniramine therapy
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
AU601736B2 (en) * 1986-05-23 1990-09-20 Sanofi Sante Nutrition Animale Sa Coated veterinary implants
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
ATE75394T1 (de) * 1986-11-14 1992-05-15 Ciba Geigy Ag Orales osmotisches system fuer metoprolol mit verbesserten formulierungseigenschaften.
JPS63135179A (ja) * 1986-11-26 1988-06-07 立花　俊郎 薬物の経皮投与具
US4801461A (en) 1987-01-28 1989-01-31 Alza Corporation Pseudoephedrine dosage form
US4915952A (en) * 1987-02-27 1990-04-10 Alza Corporation Composition comprising drug, HPC, HPMC and PEO
US4810502A (en) * 1987-02-27 1989-03-07 Alza Corporation Pseudoephedrine brompheniramine therapy
US5023076A (en) * 1987-02-27 1991-06-11 Alza Corporation Lamina comprising carboxyvinyl polymer
GB2206046B (en) * 1987-06-25 1991-04-03 Alza Corp Multi-unit delivery system
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
GR1000252B (el) * 1988-09-02 1992-05-12 Alza Corp Μορφη δοσολογιας συνισταμενη απο ταχεια απελευθερωση δραστικου παραγοντα ακολουθουμενη απο βραδεια απελευθερωση δραστικου παραγοντα.
US5034229A (en) 1988-12-13 1991-07-23 Alza Corporation Dispenser for increasing feed conversion of hog
US4969884A (en) * 1988-12-28 1990-11-13 Alza Corporation Osmotically driven syringe
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
US5200197A (en) * 1989-11-16 1993-04-06 Alza Corporation Contraceptive pill
US5045082A (en) * 1990-01-10 1991-09-03 Alza Corporation Long-term delivery device including loading dose
US5071607A (en) * 1990-01-31 1991-12-10 Alza Corporatino Method and apparatus for forming a hole in a drug dispensing device
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5221536A (en) 1990-05-07 1993-06-22 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5192550A (en) * 1990-05-07 1993-03-09 Alza Corporation Dosage form for treating central nervous system disorders
US5187100A (en) * 1990-05-29 1993-02-16 Lifescan, Inc. Dispersion to limit penetration of aqueous solutions into a membrane
US5128145A (en) * 1990-06-13 1992-07-07 Alza Corporation Dosage form for Parkinson's disease, spasticity and muscle spasms
ATE118345T1 (de) * 1990-08-07 1995-03-15 Pfizer Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen.
US5178867A (en) * 1991-08-19 1993-01-12 Alza Corporation Dosage form for delivering drug in short-time period
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5429822A (en) * 1992-03-13 1995-07-04 Cambridge Scientific, Inc. Biodegradable bursting release system
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US5540665A (en) * 1994-01-31 1996-07-30 Alza Corporation Gas driven dispensing device and gas generating engine therefor
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
US5595752A (en) * 1994-07-01 1997-01-21 Monsanto Company Increasing dressing percentage and carcass weight in finishing beef cattle
US5672357A (en) * 1994-07-01 1997-09-30 Monsanto Company Method and device for implantation of large diameter objects in bovines
US5914131A (en) * 1994-07-07 1999-06-22 Alza Corporation Hydromorphone therapy
US5529787A (en) * 1994-07-07 1996-06-25 Alza Corporation Hydromorphone therapy
US6491945B1 (en) 1994-09-16 2002-12-10 Alza Corporation Hydrocodone therapy
US6283951B1 (en) * 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
ES2168610T3 (es) * 1996-03-12 2002-06-16 Alza Corp Composicion y forma galenica que contiene un antagonista opioide.
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
US5948787A (en) * 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
BRPI9802144B1 (pt) * 1997-05-30 2017-03-28 Ezequiel Mayorga Jorge dispositivo osmótico multicapa aperfeiçoado
US8524277B2 (en) * 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
US20020127254A1 (en) * 1998-06-25 2002-09-12 Lavipharm Laboratories Inc. Devices for local and systemic delivery of active substance and methods of manufacturing thereof
US20090297602A1 (en) * 1998-11-02 2009-12-03 Devane John G Modified Release Loxoprofen Compositions
US6198966B1 (en) 1999-02-26 2001-03-06 Medtronic, Inc. Recirculating implantable drug delivery system
WO2000062759A1 (en) 1999-04-16 2000-10-26 Novo Nordisk A/S Dry, mouldable drug formulation
US6264973B1 (en) * 1999-08-26 2001-07-24 Fei Enterprises, Ltd. Apparatus and method for anesthetizing the cervical region of a female
JP2003521506A (ja) 2000-02-04 2003-07-15 アルザ・コーポレーション 浸透圧で駆動される液体ディスペンサーとコーティング組成物
US6464688B1 (en) 2000-02-15 2002-10-15 Microsolutions, Inc. Osmotic pump delivery system with flexible drug compartment
EP1313425B1 (de) * 2000-07-14 2007-03-07 Novo Nordisk A/S Verfahren zum formen einer pharmazeutischen zusammensetzung in einem verpackungsmaterial
EP1240897B1 (de) * 2001-03-14 2006-06-21 Pfizer Products Inc. Pharmazeutische Tablette und eine Verfahren zu deren Herstellung
US6632217B2 (en) * 2001-04-19 2003-10-14 Microsolutions, Inc. Implantable osmotic pump
EP1429746B1 (de) * 2001-09-28 2008-08-13 McNEIL-PPC, INC. Darreichungsformen mit kern und äusserer hülle
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US20040253312A1 (en) 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
US20030228368A1 (en) * 2001-09-28 2003-12-11 David Wynn Edible solid composition and dosage form
WO2003051328A1 (en) * 2001-12-18 2003-06-26 Novo Nordisk A/S Solid dose micro implant
US8454997B2 (en) * 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
PT1551372T (pt) * 2002-09-20 2018-07-23 Alpharma Pharmaceuticals Llc Subunidade de sequestração e composições e métodos relacionados
WO2004028513A1 (en) 2002-09-28 2004-04-08 Mcneil-Ppc, Inc. Immediate release dosage form comprising shell having openings therein
US20070077301A1 (en) * 2002-12-23 2007-04-05 Meyer Glenn A Venlafaxine osmotic device formulation
US8029822B2 (en) * 2003-05-22 2011-10-04 Osmotica Kereskedelmi és Seolgáltató KFT Rupturing controlled release device having a preformed passageway
US7402680B2 (en) * 2003-09-17 2008-07-22 Janssen Pharmaceutica, N.V. Fused heterocyclic compounds
CA2540059C (en) * 2003-09-26 2013-08-06 Alza Corporation Controlled release formulations exhibiting an ascending rate of release
US20050089570A1 (en) * 2003-09-26 2005-04-28 Evangeline Cruz Oros push-stick for controlled delivery of active agents
EP2184058B1 (de) 2003-09-26 2012-02-08 ALZA Corporation Arzneistoffcoating mit hohem Wirkstoffanteil sowie Methoden zu dessen Herstellung
CN102697704A (zh) * 2003-09-26 2012-10-03 阿尔扎公司 阿片类与非阿片类镇痛药的控释制剂
US20050129764A1 (en) * 2003-12-11 2005-06-16 Vergez Juan A. Osmotic device containing licofelone
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US7879354B2 (en) 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US20050196448A1 (en) * 2004-03-05 2005-09-08 Hai Yong Huang Polymeric compositions and dosage forms comprising the same
US20050196446A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196447A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196442A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
CA2586447C (en) * 2004-11-05 2013-10-01 Smithkline Beecham Corporation Pharmaceutical analysis apparatus and method
US20060104931A1 (en) * 2004-11-12 2006-05-18 Takeshi Fukutome Cosmetic treatment article comprising substrate and gel composition
AR053986A1 (es) 2004-12-03 2007-05-30 Osmotica Pharmaceutical Argent Dispositivo osmotico que contiene amantadina y una sal osmotica
US7530804B2 (en) * 2004-12-07 2009-05-12 Mcneil-Ppc, Inc. System and process for providing at least one opening in dosage forms
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US20060233882A1 (en) * 2005-04-15 2006-10-19 Sowden Harry S Osmotic dosage form
ZA200711123B (en) 2005-06-27 2009-08-26 Biovail Lab Int Srl Modified-release formulations of a bupropion salt
US7598255B2 (en) * 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
WO2007073702A2 (es) 2005-12-29 2007-07-05 Osmotica Corp. Comprimido multicapa con combinación de triple liberación
EP2010177A2 (de) * 2006-04-10 2009-01-07 Janssen Pharmaceutica N.V. Kombinationstherapie aus histaminrezeptor h1- und h4-antagonisten zur behandlung von juckreiz
US8137327B2 (en) * 2006-06-16 2012-03-20 Family Health International Vaginal drug delivery system and method
PL2034975T3 (pl) * 2006-06-19 2012-09-28 Alpharma Pharmaceuticals Llc Kompozycje farmaceutyczne
EP2049087A2 (de) * 2006-07-21 2009-04-22 LAB International SRL Hydrophiles missbrauchssicheres ausgabesystem
US8623418B2 (en) * 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US20100266645A1 (en) * 2007-12-17 2010-10-21 Alfred Liang Pharmaceutical compositions
US20090311335A1 (en) * 2008-06-12 2009-12-17 Scott Jenkins Combination of a triptan and an nsaid
BRPI0919249B1 (pt) 2008-09-25 2017-12-19 Isp Investments Inc. Coating composition, method for coating solids and coated product
DE102008059206A1 (de) * 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
JP2012523427A (ja) * 2009-04-09 2012-10-04 アルカーメス ファーマ アイルランド リミテッド 薬物送達組成物
PE20142284A1 (es) 2012-05-07 2014-12-17 Bayer Pharma AG Procedimiento de fabricacion de una forma de dosificacion farmaceutica que comprende nifedipina y candesartan cilexetilo
US20160310408A1 (en) 2013-12-06 2016-10-27 Durect Corporation Compositions Comprising Antioxidant, Fluid Dispensers, and Methods Involving the Same
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
WO2018115888A1 (en) 2016-12-21 2018-06-28 N4 Pharma Uk Limited Novel formulations of aprepitant
US9707217B1 (en) 2017-02-03 2017-07-18 Osmotica Kereskedelmi Es Szolgaltato Kft Dose-dumping resistant controlled release dosage form
KR102642847B1 (ko) 2017-07-10 2024-03-04 젤 캡 테크놀로지스 엘엘씨 이중 방출 투여형 캡슐 및 이를 제조하기 위한 방법, 장치 및 시스템
WO2019023617A1 (en) * 2017-07-27 2019-01-31 University Of Utah Research Foundation DEVICE FOR DELIVERY OF THERAPEUTIC PRODUCT

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2099402A (en) * 1934-01-17 1937-11-16 Pratt Food Company Pill or tablet
US2921001A (en) * 1957-04-16 1960-01-12 Sterling Drug Inc Multi-layered pill or tablet with indicating lamination
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
US3625214A (en) * 1970-05-18 1971-12-07 Alza Corp Drug-delivery device
AU466503B2 (en) * 1972-06-05 1975-10-30 Alza Corporation Osmotic dispenser
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4135514A (en) * 1974-12-23 1979-01-23 Alza Corporation Osmotic releasing system for administering ophthalmic drug to eye of animal
US4093709A (en) * 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4014334A (en) * 1976-02-02 1977-03-29 Alza Corporation Laminated osmotic system for dispensing beneficial agent
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4309996A (en) * 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
US4455143A (en) * 1982-03-22 1984-06-19 Alza Corporation Osmotic device for dispensing two different medications

Also Published As

Publication number Publication date
FR2541896B1 (fr) 1987-07-24
IL71112A (en) 1986-09-30
DK162470B (da) 1991-11-04
GB8400563D0 (en) 1984-02-15
MX165227B (es) 1992-10-30
DK88884A (da) 1984-09-05
DK88884D0 (da) 1984-02-22
DK162470C (da) 1992-04-06
IE56606B1 (en) 1991-10-09
NO170667C (no) 1992-11-18
DE3407873A1 (de) 1984-09-06
AU2306884A (en) 1984-09-06
NO170667B (no) 1992-08-10
NL192720C (nl) 1998-01-06
IE840156L (en) 1984-09-04
BE898820A (fr) 1984-05-30
GB2135880A (en) 1984-09-12
IL71112A0 (en) 1984-05-31
ES530268A0 (es) 1985-03-01
NO840725L (no) 1984-09-05
JPS59167513A (ja) 1984-09-21
DE3407873C2 (de) 1992-10-08
NL192720B (nl) 1997-09-01
NL8400670A (nl) 1984-10-01
CH660124A5 (de) 1987-03-31
CA1242122A (en) 1988-09-20
JPS644489B2 (de) 1989-01-25
SE8401185D0 (sv) 1984-03-02
IT8467204A0 (it) 1984-03-02
AT397179B (de) 1994-02-25
ES8503499A1 (es) 1985-03-01
NZ206988A (en) 1986-04-11
SE8401185L (sv) 1984-09-05
IT1182253B (it) 1987-10-05
US4576604A (en) 1986-03-18
FR2541896A1 (fr) 1984-09-07
BR8400997A (pt) 1984-10-09
ZA84259B (en) 1985-02-27
ATA72784A (de) 1993-07-15
GB2135880B (en) 1986-10-01
AU568621B2 (en) 1988-01-07

Similar Documents

Publication Publication Date Title
SE459847B (sv) Osmotiskt system med omedelbar laekemedelstillgaenglighet
US4309996A (en) System with microporous releasing diffusor
US4320759A (en) Dispenser with diffuser
US4673405A (en) Osmotic system with instant drug availability
CA1265966A (en) Rate controlled dispenser for administering beneficial agent
US4235236A (en) Device for dispensing drug by combined diffusional and osmotic operations
US4612008A (en) Osmotic device with dual thermodynamic activity
US4285987A (en) Process for manufacturing device with dispersion zone
US5082668A (en) Controlled-release system with constant pushing source
CA1222950A (en) Osmotic device with dual thermodynamic activity
US4783337A (en) Osmotic system comprising plurality of members for dispensing drug
EP0334465B1 (de) Dosierform für Verabreichung in der Humanmedizin
US4200098A (en) Osmotic system with distribution zone for dispensing beneficial agent
US4203439A (en) Osmotic system with volume amplifier for increasing amount of agent delivered therefrom
US4692336A (en) Self controlled release device for administering beneficial agent to recipient
US4298003A (en) System for delivering agent at zero order rate with emerging agent below saturation
JPS61249916A (ja) 不活性なコア部を有する浸透圧利用薬剤投与具
JPH0155242B2 (de)
JPH0655666B2 (ja) 脂質浸透ポンプ
JPH0428242B2 (de)

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8401185-7

Format of ref document f/p: F

NUG Patent has lapsed